Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-03-23 Purchase |
2021-03-24 7:21 pm |
Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer |
100,000 | $2.4818 | $248,180 | 180,426 (Direct) |
View |
2020-07-08 Purchase |
2020-07-10 6:11 pm |
Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer |
37,500 | $2.737 | $102,638 | 57,836 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-12-08 Option Award |
2021-12-09 6:31 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer |
37,567 | $0 | 278,242 (Direct) |
View |
2021-12-08 Tax Withholding |
2021-12-09 6:31 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer |
14,884 | $1.42 | 278,242 (Direct) |
View |
2021-04-15 Option Award |
2021-04-19 4:51 pm |
N/A 2031-04-14 |
Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer |
682,100 | $0 | 682,100 (Direct) |
View |
2021-03-17 Option Award |
2021-03-19 4:55 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer |
22,590 | $0 | 80,426 (Direct) |
View |
2020-06-11 Option Award |
2020-06-15 7:39 pm |
N/A N/A |
Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer |
22,591 | $0 | 42,926 (Direct) |
View |
2020-06-11 Tax Withholding |
2020-06-15 7:39 pm |
N/A N/A |
Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer |
9,755 | $3.09 | 42,926 (Direct) |
View |